Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

Phase 3 Terminated 28 enrolled Endo USA Inc., a Keenova Therapeutics Company

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy, tolerability, safety and pharmacokinetics of Oxymorphone HCl as an analgesic for acute moderate to severe post-operative pain in pediatric subjects.

Timeline

Start: 2016-04
Primary completion: 2020-07-01
Completion: 2020-09-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oxymorphone	Small molecule	—	Oral

Indications

No indication recorded.